Lobbying Activity Report

1698-46484

Organization: Hoffmann-La Roche Limited
Associated registration: 9040-1698-36
Lobbying Activity date: 2025-11-03
Arranged a meeting: No
Posted date: 2025-11-11

In-house lobbyists who participated in the lobbying activity: Carlene Todd
Robyn Henwood
Senior Public Office Holders who were lobbied in this activity: John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement Branch, Health

Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health

Ian Rongve, ADM
Health System Policy & Oversight, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Further promote the contributions and positive impact of pharmaceutical innovation and the pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health, Hospitals
Innovative medicines investment data sharing for clinical trials
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Economic Development and Trade, Finances and Budgets, Health
 
Senior officer who filed this Lobbying Activity Report: Brigitte Nolet
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: